CASI Pharmaceuticals, Inc.
(NASDAQ : CASI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.48%171.281.3%$490.30m
BIIBBiogen Inc.
-0.90%227.061.3%$435.96m
CELGCelgene Corporation
-0.41%95.241.3%$435.38m
GILDGilead Sciences, Inc.
-0.42%66.890.9%$421.14m
ILMNIllumina, Inc.
1.13%312.453.5%$304.49m
REGNRegeneron Pharmaceuticals, Inc.
-0.86%312.562.6%$284.79m
AAgilent Technologies, Inc.
0.99%68.371.6%$218.10m
VRTXVertex Pharmaceuticals Incorporated
-0.72%171.771.9%$178.12m
EXASExact Sciences Corporation
3.06%96.8825.3%$165.46m
ALXNAlexion Pharmaceuticals, Inc.
1.45%127.152.0%$148.25m
BMRNBioMarin Pharmaceutical Inc.
2.42%89.074.3%$119.32m
INCYIncyte Corporation
1.55%81.752.5%$110.60m
SRPTSarepta Therapeutics, Inc.
2.19%120.8414.7%$106.75m
ALNYAlnylam Pharmaceuticals, Inc
1.50%68.939.2%$99.72m
IONSIonis Pharmaceuticals, Inc.
-3.60%64.728.2%$96.34m

Company Profile

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.